Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Murrell

Showing results (451-460 of 491) with videos related to

Pageof 50
Sort By:
Pediatric Dermatology|May 28, 2026
Long-Term Efficacy and Safety of Oleogel-S10 (Birch Triterpenes) for Pediatric Patients With Epidermolysis BullosaEli Sprecher, Mauricio Torres-Pradilla, Maria Florencia Fernandez, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 31, 2024
Autoimmune blistering diseases treated with glucocorticoids: An international study of steroid-induced myopathyA He, B Koszegi, S Uzun, et al.
Journal of the National Cancer Institute|October 18, 2015
Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCCV L Martins, M P Caley, K Moore, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 1, 2026
Cumulative isotretinoin dosing, treatment response and acne relapse: A randomized controlled trialRuggero Cascio Ingurgio, Angela Alfano, Antonio Costanzo, et al.
The Journal of Investigative Dermatology|August 27, 2010
No evidence that human papillomavirus is responsible for the aggressive nature of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinomaKarin J Purdie, Celine Pourreyron, Hiva Fassihi, et al.
The British Journal of Dermatology|January 23, 2016
Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigusC Boulard, S Duvert Lehembre, C Picard-Dahan, et al.
The British Journal of Dermatology|November 23, 2017
International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisitaC Prost-Squarcioni, F Caux, E Schmidt, et al.
Frontiers in Medicine|November 24, 2018
Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific ConferenceJinmin Lee, Victoria P Werth, Russell P Hall, et al.
Journal of the American Academy of Dermatology|April 1, 2008
The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EBJo-David Fine, Robin A J Eady, Eugene A Bauer, et al.
International Journal of Dermatology|January 29, 2025
Quality-of-Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes and External ExpertsPavel V Chernyshov, Andrew Y Finlay, Lucia Tomas-Aragones, et al.
Pageof 50

Showing results (451-460 of 491) with videos related to

Sort By:
Pageof 50
Pediatric Dermatology|May 28, 2026
Long-Term Efficacy and Safety of Oleogel-S10 (Birch Triterpenes) for Pediatric Patients With Epidermolysis BullosaEli Sprecher, Mauricio Torres-Pradilla, Maria Florencia Fernandez, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 31, 2024
Autoimmune blistering diseases treated with glucocorticoids: An international study of steroid-induced myopathyA He, B Koszegi, S Uzun, et al.
Journal of the National Cancer Institute|October 18, 2015
Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCCV L Martins, M P Caley, K Moore, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 1, 2026
Cumulative isotretinoin dosing, treatment response and acne relapse: A randomized controlled trialRuggero Cascio Ingurgio, Angela Alfano, Antonio Costanzo, et al.
The Journal of Investigative Dermatology|August 27, 2010
No evidence that human papillomavirus is responsible for the aggressive nature of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinomaKarin J Purdie, Celine Pourreyron, Hiva Fassihi, et al.
The British Journal of Dermatology|January 23, 2016
Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigusC Boulard, S Duvert Lehembre, C Picard-Dahan, et al.
The British Journal of Dermatology|November 23, 2017
International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisitaC Prost-Squarcioni, F Caux, E Schmidt, et al.
Frontiers in Medicine|November 24, 2018
Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific ConferenceJinmin Lee, Victoria P Werth, Russell P Hall, et al.
Journal of the American Academy of Dermatology|April 1, 2008
The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EBJo-David Fine, Robin A J Eady, Eugene A Bauer, et al.
International Journal of Dermatology|January 29, 2025
Quality-of-Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes and External ExpertsPavel V Chernyshov, Andrew Y Finlay, Lucia Tomas-Aragones, et al.
Pageof 50